# Machine Representation Expert Validation No-Outreach Execution Packet v0

Stewarded by [frg.earth](https://frg.earth/).

- disease program: `multiple-myeloma`
- artifact id: `machine-representation-expert-validation-no-outreach-execution-packet-v0`
- ORP item: `machine-representation-expert-validation-no-outreach-prep-v0`
- packet status: public-safe no-outreach execution prep complete
- claim level: open-question
- clinical boundary: research-use-only, not medical advice
- communication boundary: no outreach, no private correspondence, no copied
  unpublished expert content
- last reviewed: `2026-04-20`

## Purpose

This packet executes the autonomous portion of
`machine-representation-expert-validation-execution-v0` under a strict
no-outreach constraint.

It turns the existing machine-representation source-gap queue, issue-draft
packet, expert-validation ledger, and MRD geometry falsification artifacts into
a public-safe pressure map. The packet does not contact reviewers, open new
issues, update public issue state, request private material, ingest expert
responses, or mark any claim as expert-reviewed.

## Execution Decision

Current decision: `no-outreach-public-status-prep`.

Allowed in this pass:

- connect existing public review issue slots to machine-representation review
  lenses
- connect source-gap tasks to sharper public-source pressure questions
- preserve the MRD geometry falsification outputs as stress tests for future
  machine-state wording
- state exactly which inferences remain blocked
- prepare the next no-outreach public-source extraction lane

Blocked in this pass:

- external outreach, tagging, direct contact, email, messages, or follow-up
- opening new GitHub issues or changing issue status
- copying private correspondence, unpublished expert comments, or meeting notes
- treating public issue metadata, issue presence, or comment counts as expert
  validation
- changing claim levels to expert-reviewed, clinically valid, publication-ready,
  or actionable
- using real case data, private lab material, patient-specific outputs,
  diagnosis, prognosis, treatment guidance, trial guidance, monitoring
  guidance, ranking, matching, publication authorization, or cure claims

## Source Inputs

| Input | Use In This Packet | Boundary |
| --- | --- | --- |
| [Machine Representation Source Extraction v0](../machine-representation-source-extraction-v0.md) | Provides extraction rows, source-context states, review gaps, and blocked uses. | Source-extraction rows are not model evidence or clinical validation. |
| [Machine Representation Source-Gap Task Queue v0](../public-tasks/machine-representation-source-gap-task-queue-v0.md) | Provides the 8 public source-gap tasks used for no-outreach pressure mapping. | Task readiness is public artifact readiness, not clinical priority. |
| [Machine Representation Source-Gap Issue Draft Packet v0](../public-tasks/issue-drafts/machine-representation-source-gap-issue-draft-packet-v0.md) | Provides human-reviewable issue draft text without opening issues. | Draft text remains unfiled and non-outreach. |
| [Expert Validation Issue Index v0](expert-validation-issue-index-v0.md) | Provides existing review issue slots and lens labels. | Existing issue slots do not complete expert review. |
| [Expert Response Validation Ledger v0](expert-response-validation-ledger-v0.md) | Provides safe dispositions and the current `keep-expert-review-needed` baseline. | Ledger state is not endorsement, consensus, or claim validation. |
| [Expert Validation Loop v0](expert-validation-loop-v0.md) | Provides disposition rules for public-safe expert-validation plumbing. | Loop rules block outreach and private correspondence. |
| [MRD Geometry Falsification Matrix v0](../mechanisms/mrd-geometry-falsification-matrix-v0.md) | Supplies falsifier shapes for future machine-state wording. | Falsification records do not create clinical prediction behavior. |
| [MRD Geometry Transition Model v0](../mechanisms/mrd-geometry-transition-model-v0.md) | Supplies transition vocabulary for residual-state movement. | Transition labels are research descriptors only. |
| [MRD Geometry Hypothesis Candidate Ledger v0](../mechanisms/mrd-geometry-hypothesis-candidate-ledger-v0.md) | Supplies blocked hypothesis candidates and required falsifiers. | Candidates are not options, recommendations, rankings, or cure claims. |

## No-Outreach Action Ledger

| Action | Status | Evidence |
| --- | --- | --- |
| External reviewer contact | `not_performed_blocked` | No email, direct message, tagging, meeting request, or outreach action was taken. |
| New public issue creation | `not_performed_blocked` | Existing issue draft packet remains human-reviewable draft text only. |
| Existing issue status refresh | `not_performed_blocked` | This packet does not read or update live issue metadata. Existing ledger state remains the public basis. |
| Expert-response intake | `not_performed_blocked` | No public or private response content is copied, summarized, or dispositioned here. |
| Public-source pressure mapping | `performed` | The source-gap task matrix below records no-outreach pressure questions and blocked inferences. |
| Claim status upgrade | `not_performed_blocked` | All machine-representation and MRD geometry claims remain open-question or research-use-only. |

## Existing Expert Issue Slot Status

The existing public expert-validation issues #22 through #34 remain governed by
[Expert Response Validation Ledger v0](expert-response-validation-ledger-v0.md).

For this no-outreach pass, every existing slot keeps the same safe baseline:

- current ledger disposition: `keep-expert-review-needed`
- allowed use: public-safe review/status planning only
- disallowed use: expert-review completion, endorsement, consensus,
  publication authorization, clinical validity, or patient-facing action

This packet intentionally does not refresh issue comments or statuses, because
the selected scope is no-outreach prep and not issue operations.

## Machine-Representation Pressure Matrix

| Task ID | Rows | No-Outreach Pressure Question | Prep Output | Blocked Inference |
| --- | --- | --- | --- | --- |
| `mr-modality-scope-source-extraction-task-v0` | `mse_00`, `mse_01`, `mse_02` | What exact public-source modality, cohort, follow-up, and missingness fields can be named without implying a portable patient-state model? | Keep issue draft ready; route to internal public-source extraction. | No prognosis, treatment fit, trial fit, monitoring guidance, model validation, ranking, or patient matching. |
| `mr-immune-atlas-field-source-extraction-task-v0` | `mse_03` | Which immune-atlas field families can be represented as synthetic-only descriptors while preserving sample, method, sparsity, and missingness context? | Keep issue draft ready; route to internal public-source extraction. | No immune-status advice, therapy selection, prognosis, eligibility, or real-case model input. |
| `mr-context-crosswalk-source-task-v0` | `mse_04`, `mse_07` | Which source-defined clinical, high-risk, organ, frailty, and precursor labels can be crosswalked without creating calculators or action categories? | Keep issue draft ready; route to internal public-source extraction. | No diagnosis, prognosis, screening advice, personal risk advice, treatment guidance, trial guidance, urgency, or scoring. |
| `mr-therapy-exposure-source-gap-task-v0` | `mse_05` | Which public sources define therapy class, exposure, response linkage, refractory context, toxicity, and constraint vocabulary for non-advisory timelines? | Convert gap into a no-outreach source-registry delta candidate. | No sequencing, eligibility, access guidance, treatment advice, trial advice, expanded-access guidance, or ranking. |
| `mr-endpoint-field-source-task-v0` | `mse_06` | Which method, threshold, sample, timepoint, durability, and endpoint-role fields can be extracted while preserving draft/nonbinding and non-cure boundaries? | Route to internal artifact update only after source-scoped extraction. | No cure claim, endpoint interpretation, prognosis, monitoring guidance, treatment guidance, trial guidance, or patient-specific MRD interpretation. |
| `mr-relapse-resistance-scope-task-v0` | `mse_08` | Which relapse and resistance feature families can be represented as cohort-level mechanism context separate from actionability? | Keep issue draft ready; connect to MRD geometry falsifier vocabulary. | No resistance diagnosis, treatment ranking, trial matching, mechanism ranking, target actionability, or patient option inference. |
| `mr-fusion-validation-method-source-gap-task-v0` | `mse_09`, `mse_11` | Which public method or governance sources are needed before fusion architecture and validation standards can move beyond design proposal status? | Route to internal public-source method search and governance-source extraction. | No model implementation approval, benchmark claim, clinical utility claim, deployment readiness, scoring, prediction, or model comparison. |
| `mr-output-wrapper-review-question-task-v0` | `mse_10`, `mse_12` | Are the refusal, uncertainty, missingness, calibration, and blocked-use labels strong enough to prevent synthetic placeholders from becoming patient outputs? | Preserve as internal review question set and boundary audit input. | No progression-risk output, response probability, MRD interpretation, resistance attribution, recommendation, ranking, real-case routing, or publication authorization. |

## MRD Geometry Handoff Into Machine Representation

| MRD Geometry Artifact | Machine-Representation Use | Required Boundary |
| --- | --- | --- |
| Falsification matrix | Use falsifier categories to test whether machine-state language overclaims residual-state, therapy-pressure, immune-escape, or measurement-context transitions. | Falsifiers are research tests, not patient predictions or clinical decisions. |
| Transition model | Use transition vocabulary only when the source context supports event-state movement labels. | Transition labels cannot imply sequence selection, monitoring actions, or therapeutic timing. |
| Hypothesis candidate ledger | Use candidate hypotheses as blocked review questions with required source and falsifier fields. | Hypotheses cannot be converted into candidate options, treatment paths, rankings, or cure claims. |

## Completion Criteria For This Pass

This pass is complete when:

- no-outreach execution scope is recorded
- the source-gap task queue is mapped to sharper pressure questions
- existing expert issue slots remain `keep-expert-review-needed`
- MRD geometry artifacts are connected as falsification inputs, not claim
  upgrades
- ORP state records that no external expert-validation gate was cleared

## Handoff State

`machine-representation-expert-validation-no-outreach-prep-v0` is complete as
public-safe no-outreach execution prep.

`machine-representation-expert-validation-execution-v0` remains blocked for
actual external expert-validation execution, outreach, private correspondence,
public response intake, and any expert-review claim upgrade.

The next exact control-plane state should be
`machine-representation-expert-validation-human-authorization-blocker-v0`
unless a human explicitly authorizes outreach, clears a named gate, or selects
a new named no-outreach public-source extraction phase.

## Public Safety Check

- No patient-identifying data.
- No real case data.
- No private records, reports, images, notes, exact person-linked dates, raw
  molecular values, sequencing records, portal exports, accessions, private
  paths, free-text case details, private correspondence, or re-identification
  keys.
- No private emails, unpublished expert comments, private reviewer identities,
  contact details, meeting notes, or completed outreach.
- No new issue creation, live issue status update, tagging, direct contact, or
  public request to a named person.
- No diagnosis, prognosis, treatment guidance, trial guidance, eligibility
  guidance, expanded-access guidance, monitoring guidance, urgency guidance,
  safety-management guidance, patient-specific output, recommendation, ranking,
  matching, publication authorization, or clinical decision.
- No expert-review substitution.
- No cure or vaccine claim.

## Limitations

- This is a public no-outreach execution-prep packet, not expert review.
- This does not prove that any claim is correct, complete, clinically valid,
  endorsed, consensus-backed, or publication-ready.
- This does not update live GitHub issue state or public issue comments.
- This does not open source-gap issues or send public requests.
- This does not inspect private lab records, private correspondence, or real
  case data.
- This does not close source-context gaps by itself.
- This does not implement model code, validation code, training, inference,
  calibration, benchmarking, deployment, ranking, recommendation behavior,
  patient matching, trial matching, or review-packet assembly.
- This does not authorize real case intake, private-lab access, clinical
  interpretation, public release, legal approval, regulatory readiness, sponsor
  decisions, institutional decisions, treating-team decisions, or publication.
- This does not provide medical advice, diagnostic guidance, prognosis
  guidance, treatment guidance, trial guidance, eligibility guidance,
  expanded-access guidance, monitoring guidance, safety-management guidance,
  urgency guidance, publication guidance, or a cure claim.
